Amarin Corp Plcuk (AMRN) Preferred Shares (2015 - 2020)
Amarin Corp Plcuk (AMRN) posted quarterly Preferred Shares of $5.4 million for Q3 2020, down 75.13% YoY from $21.8 million in Q4 2019, and down 24.17% sequentially from $7.2 million in Q2 2020.
Amarin Corp Plcuk (AMRN) Preferred Shares (2015 - 2020) Analysis & Trends
Amarin Corp Plcuk has disclosed Preferred Shares across 6 years of filings, most recently posting $5.4 million for Q3 2020.
- In Q3 2020, Preferred Shares fell 75.13% year-over-year to $5.4 million; the TTM figure through Sep 2020 stood at $5.4 million (down 75.13% YoY), while the FY2019 annual figure was $21.8 million, changed 0.0% from the prior year.
- Preferred Shares slipped to $5.4 million in Q3 2020, from $7.2 million in the prior quarter.
- Over the last five years, Preferred Shares for AMRN reached as high as $24.4 million in Q1 2016 and fell as low as $5.4 million in Q3 2020.
- The 5-year median for Preferred Shares is $24.4 million (2016), against an average of $21.5 million.
- Annual changes were most pronounced in 2016 — Preferred Shares increased 13.98% — and 2020, when it slumped 75.13%.
- A 5-year view of Preferred Shares shows it stood at $24.4 million in 2016, then changed by 0.0% to $24.4 million in 2017, then fell by 10.32% to $21.8 million in 2018, then changed by 0.0% to $21.8 million in 2019, then sank by 75.13% to $5.4 million in 2020.
- According to Business Quant data, Preferred Shares over the past three periods registered $5.4 million, $7.2 million, and $21.8 million for Q3 2020, Q2 2020, and Q1 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 5.43 Mn |
| Jun 30, 2020 | 7.17 Mn |
| Mar 31, 2020 | 21.85 Mn |
| Dec 31, 2019 | 21.85 Mn |
| Sep 30, 2019 | 21.85 Mn |
| Jun 30, 2019 | 21.85 Mn |
| Mar 31, 2019 | 21.85 Mn |
| Dec 31, 2018 | 21.85 Mn |
| Sep 30, 2018 | 21.85 Mn |
| Jun 30, 2018 | 24.36 Mn |
| Mar 31, 2018 | 24.36 Mn |
| Dec 31, 2017 | 24.36 Mn |
| Sep 30, 2017 | 24.36 Mn |
| Jun 30, 2017 | 24.36 Mn |
| Mar 31, 2017 | 24.36 Mn |
| Dec 31, 2016 | 24.36 Mn |
| Sep 30, 2016 | 24.36 Mn |
| Jun 30, 2016 | 24.36 Mn |
| Mar 31, 2016 | 24.36 Mn |
| Dec 31, 2015 | 24.36 Mn |